Communicators

are winners!

More News

23.05.2025
BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
13.05.2025
BioNxt Reports Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
05.05.2025
BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization
23.04.2025
BioNxt Solutions Prepares for Human Bioequivalence Study For MS
19.02.2025
BioNxt Solutions Unveils Accelerated 90-Day Plan: Global Patent Advancements, MS Clini-cal Trial, and Anti-Aging Expansion
23.01.2025
BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
21.01.2025
BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities
19.12.2024
BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP
09.12.2024
BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
02.12.2024
BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide